Jan 23, 2019

$225 billion drug giant Novartis is taking a fresh approach to cancer treatment, and it could help prepare it for a ‘doomsday scenario’

Posted by in categories: biotech/medical, existential risks

Pharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?

Read more

Comments are closed.